April 24, 2024 Press Releases AMR Action Fund Portfolio Company UTILITY Therapeutics Granted FDA approval for pivmecillinam Read More +
April 4, 2022 Press Releases AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Read More +
July 15, 2021 Press Releases The AMR Action Fund Appoints John H. Rex, MD as Chair of its Scientific Advisory Board Read More +
